635 related articles for article (PubMed ID: 15913940)
1. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results.
Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Lee JY; Paik SW; Koh KC; Lee JH
Radiology; 2000 Nov; 217(2):558-63. PubMed ID: 11058660
[TBL] [Abstract][Full Text] [Related]
3. Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma.
Luo W; Numata K; Morimoto M; Oshima T; Ueda M; Okada M; Takebayashi S; Zhou X; Tanaka K
Eur J Radiol; 2010 Jul; 75(1):91-7. PubMed ID: 19361941
[TBL] [Abstract][Full Text] [Related]
4. Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.
Rajesh S; Mukund A; Arora A; Jain D; Sarin SK
J Vasc Interv Radiol; 2013 Aug; 24(8):1235-40. PubMed ID: 23796857
[TBL] [Abstract][Full Text] [Related]
5. Is contrast-enhanced US alternative to spiral CT in the assessment of treatment outcome of radiofrequency ablation in hepatocellular carcinoma?
Ricci P; Cantisani V; Drudi F; Pagliara E; Bezzi M; Meloni F; Calliada F; Erturk SM; D'Andrea V; D'Ambrosio U; Passariello R
Ultraschall Med; 2009 Jun; 30(3):252-8. PubMed ID: 19280552
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation for hepatocellular carcinoma: utility of conventional ultrasound and contrast-enhanced ultrasound in guiding and assessing early therapeutic response and short-term follow-up results.
Du J; Li HL; Zhai B; Chang S; Li FH
Ultrasound Med Biol; 2015 Sep; 41(9):2400-11. PubMed ID: 26055968
[TBL] [Abstract][Full Text] [Related]
7. Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent.
Choi D; Lim HK; Lee WJ; Kim SH; Kim YH; Kim SH; Lim JH
J Ultrasound Med; 2003 Nov; 22(11):1163-72. PubMed ID: 14620886
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation.
Vilana R; Llovet JM; Bianchi L; Sanchez M; Pagés M; Sala M; Gilabert R; Nicolau C; Garcia A; Ayuso C; Bruix J; Bru C;
J Clin Ultrasound; 2003; 31(3):119-28. PubMed ID: 12594796
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT.
Lim HK; Choi D; Lee WJ; Kim SH; Lee SJ; Jang HJ; Lee JH; Lim JH; Choo IW
Radiology; 2001 Nov; 221(2):447-54. PubMed ID: 11687689
[TBL] [Abstract][Full Text] [Related]
10. Use of fusion imaging combining contrast-enhanced ultrasonography with a perflubutane-based contrast agent and contrast-enhanced computed tomography for the evaluation of percutaneous radiofrequency ablation of hypervascular hepatocellular carcinoma.
Numata K; Fukuda H; Morimoto M; Kondo M; Nozaki A; Oshima T; Okada M; Takebayashi S; Maeda S; Tanaka K
Eur J Radiol; 2012 Oct; 81(10):2746-53. PubMed ID: 22197088
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic response assessment of high intensity focused ultrasound therapy for uterine fibroid: utility of contrast-enhanced ultrasonography.
Zhou XD; Ren XL; Zhang J; He GB; Zheng MJ; Tian X; Li L; Zhu T; Zhang M; Wang L; Luo W
Eur J Radiol; 2007 May; 62(2):289-94. PubMed ID: 17258417
[TBL] [Abstract][Full Text] [Related]
12. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation of liver cancer: early evaluation of therapeutic response with contrast-enhanced ultrasonography.
Choi D; Lim HK; Lee WJ; Kim SH; Kim MJ; Kim SK; Jang KM; Lee JY; Lim JH
Korean J Radiol; 2004; 5(3):185-98. PubMed ID: 15467416
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma treated with radiofrequency ablation: comparison of pulse inversion contrast-enhanced harmonic sonography, contrast-enhanced power Doppler sonography, and helical CT.
Meloni MF; Goldberg SN; Livraghi T; Calliada F; Ricci P; Rossi M; Pallavicini D; Campani R
AJR Am J Roentgenol; 2001 Aug; 177(2):375-80. PubMed ID: 11461867
[TBL] [Abstract][Full Text] [Related]
15. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio frequency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent.
Choi D; Lim HK; Kim SH; Lee WJ; Jang HJ; Kim H; Lee SJ; Lim JH
J Ultrasound Med; 2002 Apr; 21(4):391-401. PubMed ID: 11934096
[TBL] [Abstract][Full Text] [Related]
16. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
[TBL] [Abstract][Full Text] [Related]
17. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
[TBL] [Abstract][Full Text] [Related]
18. Fatty hepatocellular carcinoma: radiofrequency ablation--imaging findings.
Pupulim LF; Hakimé A; Barrau V; Abdel-Rehim M; Zappa M; Vilgrain V
Radiology; 2009 Mar; 250(3):940-8. PubMed ID: 19164699
[TBL] [Abstract][Full Text] [Related]
19. Recurrent hepatocellular carcinoma: percutaneous radiofrequency ablation after hepatectomy.
Choi D; Lim HK; Kim MJ; Lee SH; Kim SH; Lee WJ; Lim JH; Joh JW; Kim YI
Radiology; 2004 Jan; 230(1):135-41. PubMed ID: 14631050
[TBL] [Abstract][Full Text] [Related]
20. Subcapsular liver tumors treated with percutaneous radiofrequency ablation: a prospective comparison with nonsubcapsular liver tumors for safety and effectiveness.
Sartori S; Tombesi P; Macario F; Nielsen I; Tassinari D; Catellani M; Abbasciano V
Radiology; 2008 Aug; 248(2):670-9. PubMed ID: 18519740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
